Introduction of National AIDS Spending Assessment (NASA) to the National Advisory Committee on AIDS in Fiji. Jahnsen J. (2009)

immage

This report supports the proposed UNDP financed technical assistance intended to introduce the National AIDS Spending Assessment methodology to the National Advisory Committee (NACA). Further development, implementation and institutionalization of the NASA methodology is expected to be lead by the NACA in order to standardize the classification of HIV and AIDS expenditures among all stakeholders. It is projected that NACA’s analysis of the tracked expenditures will enable valuable information to be disclosed that will influence the strategic allocation of future resources to Fiji’s HIV/AIDS initiative. Data generated through NASA can also be used to measure the nation’s commitment and effort, which is an important component of the UNGASS Declaration, and therefore will also help Fiji to address some of the gaps that currently exist in its UNGASS reporting.

Download Publication

Economic Aspect of HIV/AIDS Control and Injecting Drug Use in Indonesia. Siregar AYM, Komarudin D, Leuwol B, et al (2009)

Technical Annex for a Proposed Grant in the Amount of SDR 6.60 Million (US$lO.O Million Equivalent) to the Islamic Republic of Afghanistan for a HIV/AIDS Prevention Project. World Bank (2007)

In Indonesia, the HIV epidemic is increasing, and among the fastest growing in Asia. The epidemic is concentrated among injecting drug users (IDUs) and their sexual partners in most parts of the country, but generalised in some other parts.


Download this publication

National HIV/AIDS Action Plan and Budget 2005-06: A Public/Private Partnership to Scale Up the HIV/AIDS Response in Nepal. Ministry of Health Nepal (2008)

National HIV/AIDS Action Plan and Budget 2005-06: A Public/Private Partnership to Scale Up the HIV/AIDS Response in Nepal. Ministry of Health Nepal (2008) The National HIV/AIDS Action Plan and Budget for 2005-2006 was produced following extensive consultation about the extent of the problem, and what needs to be done about it. Stakeholders – i.e. government officials, representatives of beneficiary groups, broader civil society actors, and donor partners – are all agreed that the Action Plan provides the single point of reference for the HIV/AIDS response in Nepal.

Download this publication

Technical Report: AIDS Spending in Indonesia 2006-2007 (Draft). National AIDS Commission Indonesia and UNAIDS (2007)

Technical Report: AIDS Spending in Indonesia 2006-2007 (Draft). National AIDS Commission Indonesia and UNAIDS (2007) The National AIDS Spending Assessment (NASA) is a tool/ method that had been introduced by the UNAIDS Geneva to measure the commitment of a nation in combating a global epidemic disease such as HIV and AIDS. The development of NASA 2006-2007 is a jointly teamwork involved highly motivated senior staffs of the National AIDS Commission, UNAIDS Indonesia, Department of Health and other Sectors at the central level, as well as colleagues from 3 selected provinces.

Download this publication

Background Report: Cost-effectiveness of Injecting Drug User Interventions to Prevent HIV in Nepal. Alban A and Manuel C (2007)

Background Report: Cost-effectiveness of Injecting Drug User Interventions to Prevent HIV in Nepal. Alban A and Manuel C (2007) This paper has two objectives. The first is to examine the robustness of two different epidemiological models; these models were used to determine the impact of IDU interventions in Nepal when interventions are scaled-up to reach 60% of IDUs, as recommended by UNAIDS. The second objective is to disseminate the outcome of two cost- effectiveness analyses of IDU interventions in Nepal. These analyses used identical data sets to determine the cost-effectiveness ratios under various scenarios of intervention coverage.

Download this publication

Modelling the Impact and Cost-effectiveness of the HIV Intervention Programme amongst Commercial Sex Workers in Ahmedabad, Gujarat, India. Fung IC, Guinness L, Vickerman P, et al (2007)

Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India. Fung IC, Guinness L, Vickerman P, et al (2007) Ahmedabad is an industrial city in Gujarat, India. In 2003, the HIV prevalence among commercial sex workers (CSWs) in Ahmedabad reached 13.0%. In response, the Jyoti Sangh HIV prevention programme for CSWs was initiated, which involves outreach, peer education, condom distribution, and free STD clinics. Two surveys were performed among CSWs in 1999 and 2003. This study estimates the cost-effectiveness of the Jyoti Sangh HIV prevention programme.

Download this publication

Technical Annex for a Proposed Grant for a HIV/AIDS Prevention Project: Afghanistan. World Bank (2007)

Technical Annex for a Proposed Grant in the Amount of SDR 6.60 Million (US$lO.O Million Equivalent) to the Islamic Republic of Afghanistan for a HIV/AIDS Prevention Project. World Bank (2007) The project will contribute to the national development goals of the Interim Afghanistan National Development Strategy (I-ANDs) o f maintaining Human Immunodeficiency Virus (HIV) prevalence below 0.5 percent in the general population and below 5 percent among vulnerable groups at high risk of infection.

Download this publication

Financing the Response to AIDS: 2006 Report on the Global AIDS Epidemic. UNAIDS (2006)

Financing the Response to AIDS: 2006 Report on the Global AIDS Epidemic. UNAIDS (2006) From UNAIDS’ launch in 1996 until 2005, available annual funding for the response to AIDS in low- and middle-income countries increased 28-fold, from US$ 300 million to US$ 8.3 billion. Existing pledges, commitments and trends suggest the rate of increase may be declining and that available funds will be US$ 8.9 billion in 2006 and US$ 10 billion in 2007.

Download this publication

Asia Pacific Regional Report on National AIDS Spending Assessment 2000-2004 (Draft). Tangcharoensathien V, Chokchaicharn H, Tisayaticom K, et al (2006)

Asia Pacific Regional Report on National AIDS Spending Assessment 2000-2004 (Draft). Tangcharoensathien V, Chokchaicharn H, Tisayaticom K, et al (2006)

Tracking how much resources were spent on HIV/AIDS as well as forecasting resource needs for scaling up responses are important inputs for effective national and global responses to the AIDS pandemic. Efficient allocation of international financial assistance and national resources for HIV/AIDS should be guided by transparent information on sources and uses of funds. The lack of timely, accurate information about spending represents a key constraint for policy decision on effective use of limited resources in developing countries.

The needs to further improve data systems are clear. At present, there has been limited success in establishing resource tracking system and a comprehensive information regarding where those funds came from and how they were spent. As a result, policy makers are unlikely to be able to effectively mobilize additional resources and allocate them toward the populations and types of services that are vital to confront the HIV/AIDS epidemic.



Download this publication

Macroeconomic Impact of HIV/AIDS in the Asian and Pacific Region. Tandon, A (2005)

Macroeconomic Impact of HIV/AIDS in the Asian and Pacific Region. Tandon, A (2005) Widespread prevalence of diseases such as Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome or HIV/AIDS, malaria, and tuberculosis are a significant constraint to development in low- and middle-income countries. The impact of HIV/AIDS has been especially devastating in sub-Saharan Africa where some countries are now seeing declines in life expectancy of up to 20 years as a result of the disease taking on pandemic proportions in the continent. Globally, HIV/AIDS is now the leading cause of adult mortality (WHO 2004). In 2004, an estimated 4.9 million deaths worldwide were attributable to HIV/AIDS (UNAIDS and WHO 2004). Given an average lag of 10 years between infection and death, the morbidity effects for an estimated 39.4 million people now living with HIV/AIDS are also substantial.

Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Jul
28
(28 Jul - 28 Jul)
Aug
12
(12 Aug - 12 Aug)